An animal model for acute and persistent Epstein-Barr Virus infection

Science

Volumn 276, Issue 5321, 1997, Pages 2030-2033

  Moghaddam, Amir ^a   Rosenzweig, Michael ^a   Lee Parritz, David ^a   Annis, Bethany ^a   Johnson, R Paul ^a   Wang, Fred ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; EPSTEIN BARR VIRUS; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RHESUS MONKEY; SEROLOGY; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCRYPTOVIRUS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MOUTH; OROPHARYNX; RECEPTORS, IGE; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR VIRUS INFECTIONS; VIRUS LATENCY; VIRUS SHEDDING;

EID: 0030810740     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.276.5321.2030     Document Type: Article

References (33)

1. E. Kieff, in Virology, D. Knipe, B. Fields, P. Howley, Eds. (Raven, Philadelphia, PA, 1996), pp. 2343-2396.
2. G. Henle, W. Henle, V. Diehl, Proc. Natl. Acad. Sci. U.S.A. 59, 94 (1968).
3. A. B. Rickinson and E. Kieff, in Virology, D. Knipe, B. Fields, P. Howley, Eds. (Raven, Philadelphia, PA, 1996), pp. 2397-2446.
4. D. E. Mosier et al., Curr. Top. Microbiol. Immunol. 166, 317 (1990).
5. T. Shope, D. Dechairo, G. Miller, Proc. Natl. Acad. Sci. U.S.A. 70, 2487 (1973).
6. D. V. Ablashi, P. Gerber, J. Easton, Comp. Immunol. Microbiol. Infect. Dis. 2, 229 (1979).
7. A. Frank, W. A. Andiman, G. Miller, Adv. Cancer Res. 23, 171 (1976).
8. M. Heller, P. Gerber, E. Kieff, J. Virol. 37, 698 (1981).
9. J. J. Ryon et al., ibid. 67, 4006 (1993).
10. M. Franken, B. Annis, A. Ali, F. Wang, ibid. 69, 8011 (1995).
11. P. Gerber, S. S. Kalter, G. Schidlovsky, W. J. Peterson, M. D. Daniel, Int. J. Cancer 20, 448 (1977).
12. D. D. Loeb et al., J. Virol. 64, 2876 (1990).
13. P. D. Ling and S. D. Hayward, ibid. 69, 1944 (1995).
14. M. Franken et al., ibid. 70, 7819 (1996).
15. J. A. Levy, S. B. Levy, Y. Hirshaut, G. Kafuko, A. Prince, Nature 233, 559 (1971).
16. V. C. Dunkel, T. W. Pry, G. Henle, W. Henle, J. Natl. Cancer Inst. 49, 435 (1972).
17. S. S. Kalter, R. L. Heberling, J. J. Ratner, Nature 238, 353 (1972).
18. H. Feichtinger et al., J. Exp. Med. 176, 281 (1992).
19. P. Gerber, J. W. Branch, E. N. Rosenblum, Proc. Soc. Exp. Biol. Med. 130, 14 (1969).
20. P. H. Levine et al., Arch. Virol. 66, 341 (1980).
21. A. Moghaddam, J. Koch, B. Annis, F. Wang, in preparation.
22. S. R. Rangan, L. N. Martin, B. E. Bozelka, N. Wang, B. J. Gormus, Int. J. Cancer 38, 425 (1986).
23. C. Kintner and B. Sugden, Nature 294, 458 (1981).
24. D. Thorley-Lawson, L. M. Nadler, A. K. Bhan, R. T. Schooley, J. Immunol. 134, 3007 (1985).
25. S. Furukawa et al., J. Infect. Dis. 166, 691 (1992).
26. Increased size and granularity were determined by increased side and forward light scatter on FACS.
27. Q. Y. Yao, A. B. Rickinson, M. A. Epstein, Int. J. Cancer 35, 35 (1985).
28. C. Alfieri et al., Blood 87, 812 (1996).
29. J. W. Gratama et al., Transplant Proc. 21, 3097 (1989).
30. L. Heston, M. Rabson, N. Brown, G. Miller, Nature 295, 160 (1982).
31. M. D. Daniel et al., Int. J. Cancer 41, 601 (1988).
32. L. Young et al., N. Engl. J. Med. 321, 1080 (1989).
33. Supported by USPHS grants CA68051 and CA65319 and by USPHS grant P51RR00168 to the NERPRC. E. Kieff and R. Desrosiers provided advice. P. Sehgal, E. Roberts, and the NERPRC staff provided assistance with animal care. D. Marks provided assistance in flow cytometry. J. Sample provided a highly inducible P3HR-1 cell line originally derived by G. Miller. All animal care was provided in accordance with institutional guidelines.